Figure 7.
Effect of HSA–Trx or Tamiflu® on pulmonary virus replication in influenza-infected mice. HSA–Trx (3.5 nmol/mouse) was administered intravenously at 4 and 6 days after the virus infection. Tamiflu® (5 mg/kg) was administrated intraperitonealy every day at 2 times per day for a total of 4 days starting on 2 day after the influenza infection. The virus titles in lung tissue were determined at 4 and 6 days after the virus injection. Each value represents the mean ± SE (n = 5).
